PULMONARY AND HEPATIC GENE-EXPRESSION FOLLOWING CECAL LIGATION AND PUNCTURE - MONOPHOSPHORYL LIPID-A PROPHYLAXIS ATTENUATES SEPSIS-INDUCED CYTOKINE AND CHEMOKINE EXPRESSION AND NEUTROPHIL INFILTRATION
Ca. Salkowski et al., PULMONARY AND HEPATIC GENE-EXPRESSION FOLLOWING CECAL LIGATION AND PUNCTURE - MONOPHOSPHORYL LIPID-A PROPHYLAXIS ATTENUATES SEPSIS-INDUCED CYTOKINE AND CHEMOKINE EXPRESSION AND NEUTROPHIL INFILTRATION, Infection and immunity, 66(8), 1998, pp. 3569-3578
Polymicrobial sepsis induced by cecal ligation and puncture (CLP) repr
oduces many of the pathophysiologic features of septic shock In this s
tudy, we demonstrate that mRNA for a broad range of pro- and anti-infl
ammatory cytokine and chemokine genes are temporally regulated after C
LP in the lung and liver. We also assessed whether prophylactic admini
stration of monophosphoryl lipid A (MPL), a nontoxic derivative of lip
opolysaccharide (LPS) that induces endotoxin tolerance and attenuates
the sepsis syndrome in mice after CLP, would alter tissue-specific gen
e expression post-CLP, Levels of pulmonary interleukin-6 (IL-6), tumor
necrosis factor alpha (TNF-alpha), granulocyte colony-stimulating fac
tor (G-CSF), IL-1 receptor antagonist (IL-1ra), and IL-10 mRNA, as wel
l as hepatic IL-1 beta, IL-6, gamma interferon (IFN-gamma), G-CSF, ind
ucible nitric oxide synthase, and IL-10 mRNA, were reduced in MPL-pret
reated mice after CLP compared to control mice. Chemokine mRNA express
ion was also profoundly mitigated in MPL-pretreated mice after CLP. Sp
ecifically, levels of pulmonary and hepatic macrophage inflammatory pr
otein 1 alpha (MIP-1 alpha), MIP-1 beta, MIP-2, and monocyte chemoattr
actant protein-1 (MCP-1) mRNA, as well as hepatic IFN-gamma-inducible
protein 10 and KC mRNA, were attenuated in MPC-pretreated mice after C
LP, Attenuated levels of IL-6, TNF-alpha, MCP-1, MIP-1 alpha, and MIP-
2 in serum also were observed in MPG-pretreated mice after CLP. Dimini
shed pulmonary chemokine mRNA production was associated with reduced n
eutrophil margination and pulmonary myeloperoxidase activity. These da
ta suggest that prophylactic administration of MPL mitigates the sepsi
s syndrome by reducing chemokine production and the recruitment of inf
lammatory cells into tissues, thereby attenuating the production of pr
oinflammatory cytokines.